SCALE BIOSCIENCES, INC

SCALE BIOSCIENCES, INC specializes in the development and manufacturing of advanced RNA-based biological kits for research and diagnostic applications. Their core capabilities center on precision molecular reagent design, scalable GMP-compliant production of RNA extraction and stabilization products, and end-to-end process validation for sensitive nucleic acid workflows. The company demonstrates deep expertise in RNA integrity preservation, lyophilized formulation, and closed-system kit assembly—critical for downstream applications in single-cell sequencing, spatial transcriptomics, and high-sensitivity gene expression analysis. Their technical differentiation lies in optimizing kit performance under variable environmental conditions, ensuring reproducibility across decentralized laboratory settings without compromising sample fidelity. The contractor has established a consistent relationship with the Department of Health and Human Services, delivering specialized biological manufacturing solutions aligned with public health research initiatives. Their work supports HHS-funded programs focused on infectious disease surveillance, genomic characterization, and biodefense preparedness, where rapid deployment of reliable RNA reagents is essential. This recurring engagement suggests a trusted partnership built on regulatory adherence, quality control rigor, and timely delivery of mission-critical reagent systems. SCALE BIOSCIENCES operates primarily within the biological product manufacturing sector (NAICS 325414), focusing on non-diagnostic RNA reagents used in life sciences research and government-funded biomedical projects. Their market positioning is niche but strategic—serving the growing demand for standardized, high-purity RNA kits that enable reproducible results in next-generation sequencing and molecular biology workflows, particularly in federally supported laboratories. As a small business structured as a 2L entity based in San Diego, California, SCALE BIOSCIENCES leverages its proximity to major research institutions and biotech ecosystems to support federal science priorities. While currently holding no formal government certifications, its operational focus on controlled manufacturing environments and quality systems aligns with federal biologics standards. The company’s geographic base positions it well to serve West Coast federal research centers and national biodefense initiatives.